Volume 66 Received 21 January 2010 | ||||||||||
| ||||||||||
aSchool of Chemistry, Bharathidasan University, Tiruchirappalli 620 024, Tamilnadu, India
Correspondence e-mail: tommtrichy@yahoo.co.in
In the title 1:1 adduct, C6H9N3·C7H7NO2, the crystal structure is stabilized by hydrogen bonds involving two different R22(8) motifs. One of them is formed by the interaction of 2-amino-4,6-dimethylpyrimidine (AMPY) with the carboxyl group of anthranilic acid (AA) through N-H
O and O-H
N hydrogen bonds, whereas the other is formed through the interaction of two centrosymmetrically related pyrimidines involving N-H
N hydrogen bonds. These two combined motifs form a heterotetramer. The heterotetramer sheets are stacked into three-dimensional network.
For the importance the reaction of aminopyrimidine derivatives and carboxylic acids in protein-nucleic acid recognition and drug binding, see: Hunt et al. (1980
); Baker & Santi (1965
). For pyrimidine-carboxylic acid interactions, see: Allen et al. (1999
). For co-crystals of AMPY, see: Balasubramani et al. (2005
, 2006
); Devi & Muthiah (2007
). For hydrogen-bonded synthons, see: Thakur & Desiraju (2008
). For packing patterns in 2-amino-4,6-dimethylpyrimidine-salicylate, see: Muthiah et al. (2006
). For typical geometric parameters in aromatic stacking, see: Hunter (1994
).
|
|
|
Data collection: APEX2 (Bruker, 2008
); cell refinement: SAINT (Bruker, 2008
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: PLATON (Spek, 2009
); software used to prepare material for publication: PLATON.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: KP2248 ).
The authors thank the DST-India (FIST programme) for the use of diffractometer at the School of Chemistry, Bharathidasan University.
Allen, F. H., Motherwell, W. D. S., Raithby, P. R., Shields, G. P. & Taylor, R. (1999). New J. Chem. pp. 25-34.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Baker, B. R. & Santi, D. V. (1965). J. Pharm. Sci. 54, 1252-1257.
![[ISI]](../../../../../../logos/isiborder.gif)
Balasubramani, K., Muthiah, P. T. & Lynch, D. E. (2006). Acta Cryst. E62, o2907-o2909.
![[details]](../../../../../../e/graphics/details.gif)
Balasubramani, K., Muthiah, P. T., RajaRam, R. K. & Sridhar, B. (2005). Acta Cryst. E61, o4203-o4205.
![[details]](../../../../../../e/graphics/details.gif)
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Devi, P. & Muthiah, P. T. (2007). Acta Cryst. E63, o4822-o4823.
![[details]](../../../../../../e/graphics/details.gif)
Hunt, W. E., Schwalbe, C. H., Bird, K. & Mallinson, P. D. (1980). J. Biochem. 187, 533-536. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Hunter, C. A. (1994). Chem. Soc. Rev. 23, 101-109.
![[ISI]](../../../../../../logos/isiborder.gif)
Muthiah, P. T., Balasubramani, K., Rychlewska, U. & Plutecka, A. (2006). Acta Cryst. C62, o605-o607.
![[details]](../../../../../../c/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Thakur, T. S. & Desiraju, G. R. (2008). Cryst. Growth Des. 8, 4031-4044.
![[ChemPort]](../../../../../../logos/chemportborder.gif)